G-201(Tcrcure Biopharma)

N/A

Report date: 2024/05/31 17:43:38

Base Information

Drug NameG-201(Tcrcure Biopharma)
Drug Alias NameG-201(Tcrcure Biopharma)G201(Tcrcure Biopharma)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsLiver NeoplasmsDigestive System Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesTcrcure Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTcrcure Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsDigestive System Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A